United States · Platforms & data · Seeking Alpha

Boston Scientific anticipates Q4 2026 organic revenue down 3% to down 1% and adjusted EPS $0.77-$0.79 amid cyber and EP/WATCHMAN pressure

Published by Seeking Alpha · United States 1 h ago

Read the full article on Seeking Alpha Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (seekingalpha.com)

Also worth reading

Independent Bank (NASDAQ:IBCP) Stock Price Target Raised at DA Davidson

Oracle expects to turn cash flow positive in second half of fiscal 2028

Vertiv earnings just sent an upbeat signal about AI ahead of Big Tech results

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Fed meeting live updates: No hike expected, but all eyes on Warsh for what's next

Market News